Influx Healthtech Schedules Board Meeting to Approve H1 FY27 Results
Influx Healthtech Ltd 路 Intimation 路 04 Nov 2026, 5:30 am
Influx Healthtech Schedules Board Meeting to Approve H1 FY27 Results Influx Healthtech Limited has scheduled its Board of Directors meeting for 4th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed for directors, promoters, designated persons, and their immediate relatives until 48 hours after the dissemination of the results.
Original exchange filing (PDF)
More announcements from Influx Healthtech Ltd
- Influx Healthtech Limited has informed the Exchange about Transcript of Investor Conference call held on November 5, 2026 路 09 Nov 2026
- Influx Healthtech Limited has informed the Exchange about Link of Recording of Investor Conference Call held on November 5, 2026 路 05 Nov 2026
- Influx Healthtech Limited has informed the Exchange about Investor Presentation 路 05 Nov 2026
- Influx Healthtech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Influx Healthtech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
- Influx Healthtech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
- Influx Healthtech Limited has informed the Exchange about Schedule of Investor Conference Call 路 05 Nov 2026
- INFLUX HEALTHTECH LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 04 Nov 2026
